Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Publication year range
1.
Neoplasma ; 65(1): 113-123, 2018.
Article in English | MEDLINE | ID: mdl-29322795

ABSTRACT

The aim of this study was a detailed clinicopathological investigation of sinonasal NUT midline carcinoma (NMC), including analysis of DNA methylation and microRNA (miRNA) expression. Three (5%) cases of NMC were detected among 56 sinonasal carcinomas using immunohistochemical screening and confirmed by fluorescence in situ hybridization. The series comprised 2 males and 1 female, aged 46, 60, and 65 years. Two tumors arose in the nasal cavity and one in the maxillary sinus. The neoplasms were staged pT1, pT3, and pT4a (all cN0M0). All patients were treated by radical resection with adjuvant radiotherapy. Two patients died 3 and 8 months after operation, but one patient (pT1 stage; R0 resection) experienced no evidence of disease at 108 months. Microscopically, all tumors consisted of infiltrating nests of polygonal cells with vesicular nuclei, prominent nucleoli and basophilic cytoplasm. Abrupt keratinization was present in only one case. Immunohistochemically, there was a diffuse expression of cytokeratin (CK) cocktail, CK7, p40, p63, and SMARCB1/INI1. All NMCs tested negative for EBV and HPV infection. Two NMCs showed methylation of RASSF1 gene. All other genes (APC, ATM, BRCA1, BRCA2, CADM1, CASP8, CD44, CDH13, CDKN1B, CDKN2A, CDKN2B, CHFR, DAPK1, ESR1, FHIT, GSTP1, HIC1, KLLN, MLH1a, MLH1b, RARB, TIMP3, and VHL) were unmethylated. All NMCs showed upregulation of miR-9 and downregulation of miR-99a and miR-145 and two cases featured also upregulation of miR-21, miR-143, and miR-484. In summary, we described three cases of sinonasal NMCs with novel findings on DNA methylation and miRNA expression, which might be important for new therapeutic strategies in the future.


Subject(s)
Carcinoma/genetics , DNA Methylation , MicroRNAs/genetics , Neoplasm Proteins/genetics , Nose Neoplasms/genetics , Nuclear Proteins/genetics , Aged , Female , Humans , In Situ Hybridization, Fluorescence , Male , Middle Aged
2.
Physiol Res ; 66(6): 987-992, 2017 12 20.
Article in English | MEDLINE | ID: mdl-28937251

ABSTRACT

Psoriatic lesions are characterized by hyperproliferation, aberrant differentiation of keratinocytes resistant to apoptosis and inflammation. miR-31 plays pro-proliferative, pro-differentiative and pro-inflammatory roles and modulates apoptosis in psoriatic keratinocytes. Endothelin-1 (ET-1) is produced by psoriatic keratinocytes and suppresses apoptosis. Inflammation increases the production of ET-1, which in turn leads to the chronic stimulation of keratinocyte proliferation. The aim of this study was to identify the putative link between two potential biomarkers (miR-31 and ET-1) in patients with psoriasis. The study design included experimental group (29 patients with psoriasis), and the control group (22 blood donors). The PASI score evaluated the state of the disease (median: 18.6; interquartile range 14.5-20.9). Both, the serum level of ET-1 and the whole blood level of miR-31 were significantly increased (p<0.001 and p<0.05, respectively) in patients compared to the controls. However, a significant negative relationship between ET-1 and miR-31 was observed (Spearman's rho=-037, p=0.05). It is possible that a negative feedback loop will be present between miR-31 and ET-1. Our results indicate that miR-31 and ET-1, potential biomarkers of the disease, play significant roles in the pathophysiology of psoriasis.


Subject(s)
Circulating MicroRNA/blood , Endothelin-1/blood , MicroRNAs/blood , Psoriasis/blood , Adolescent , Adult , Aged , Biomarkers/blood , Case-Control Studies , Circulating MicroRNA/genetics , Female , Humans , Male , MicroRNAs/genetics , Middle Aged , Psoriasis/diagnosis , Psoriasis/genetics , Psoriasis/physiopathology , Severity of Illness Index , Up-Regulation , Young Adult
3.
Neoplasma ; 23(6): 645-65, 1976.
Article in English | MEDLINE | ID: mdl-1004661

ABSTRACT

In patients with Hodgkin's disease the excretion of pyrimidine deoxyribonucleosides in urine was followed up within the course of 92 chemotherapeutical series with cytostatics of COOP group. In 14-day chemotherapy series, the excretion of deoxycytidine, deoxyuridine, thymidine, and their sum was significantly increased. In this paper the results are analyzed and a possibility of utilization of this finding for the judgment in the clinical course of the disease is considered.


Subject(s)
Deoxycytidine/urine , Deoxyuridine/urine , Hodgkin Disease/urine , Thymidine/urine , Cyclophosphamide/therapeutic use , Drug Therapy, Combination , Female , Hodgkin Disease/drug therapy , Humans , Male , Prednisone/therapeutic use , Procarbazine/therapeutic use , Sex Factors , Splenectomy , Vinblastine/therapeutic use , Vincristine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL